Chief Physician for the Department of Blood Diseases, with a specialty affiliation to Allogeneic Hematopoietic Stem Cell Transplantation, with particular professional responsibility for transplantation

The Center for Cancer and Organ Diseases' Department of Blood Diseases has a full-time position as Chief Physician available for filling from January 1, 2027.

The department's responsibilities and tasks

The Department of Blood Diseases RH is a hematology department that handles all diagnoses and treatments within the specialty. The department has the Region Capital as its catchment area, and has a national function for allogeneic stem cell transplantation and erythrocyte diseases, and covers the hematological function in the Faroe Islands.

The department has an extensive program for systematic education in blood diseases and related topics of internal medical interest.

The department has a large clinical research unit with many actively recruiting protocols, including phase 1 protocols and a recently established platform trial Blood Dose. In addition, the department is associated with strong research groups that conduct translational clinical research, basic research and epidemiological research in relation to many hematological diagnoses.

The position

The position is a Chief Physician role with connection to the specialist group for Allogeneic Hematopoietic Stem Cell Transplantation. The position is associated with on-call duties, as one participates in the hematology on-call function and performs ward rounds on weekends and holidays, and participates in the specialized telephone advisory on-call for allogeneic hematopoietic stem cell transplantation.

Linked to the position is a role as the professional responsible for transplantation of patients with Acute Myeloid Leukemia.

Additionally, a function as scheduler for the myeloid and allogeneic transplanting specialist group as well as the department's educational physicians is attached to the position.

Candidate

The position is to be filled with a specialist in internal medicine; hematology, who at the time of appointment has a minimum of 5 years' experience as a specialist in hematology, and who has substantial experience independently at the specialist level to assume responsibility for the entire patient treatment pathway within allogeneic hematopoietic stem cell transplantation. Furthermore, a colleague with a particularly documented interest and experience in myeloid stem cell diseases is desired, who will be able to bear the professional responsibility for allogeneic transplantation of Acute Myeloid Leukemia.

With regard to the role in workforce planning, the recruitment process will place emphasis on experience with the duty roster system Optima and coordination with operational processes. In addition, a colleague with strong skills in professional-cultural and cross-disciplinary collaboration is sought.

A core value in Rigshospitalet's strategy is to be of benefit to the individual patient and the health system as a whole. This dualism requires attention to both overarching and political priorities as well as joint decision-making. With regard to the position's key role in referral and planning of allogeneic transplantation, a candidate who can document experience with regulatory processes as well as experience with initiative and co-leadership within treatment culture and patient value is desired.

Further information

Further information can be obtained by contacting Chief Physician Peter Kampmann at tel. 35 45 17 33.

Salary and employment terms in accordance with the agreement between the Danish Regions and the Association of Specialists.

Applications should be prepared in relation to the Danish Health Authority's latest revision of the seven physician roles from 2026 and should include a copy of the specialist authorization as well as a CV that documents relevant experience in relation to the job advertisement.

Applications should be submitted via the link on this page.

Application deadline is 31 October 2026.

After the application deadline, a written suitability assessment will be carried out based on the application and CV by two chief physicians at highly specialized Danish hematology departments and, after that, invited to an interview.

Application deadline: 31 October 2026

Location: Rigshospitalet